NCT01905904View on ClinicalTrials.gov

Sevoflurane in Electroconvulsive Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
ECTAnesthesia
Interventions
DRUG

sevorane

Sevorane 4% Sevorane 7%

Trial Locations (1)

44100

Inonu Unıversity School of Medicine, Malatya

All Listed Sponsors
lead

Inonu University

OTHER

NCT01905904 - Sevoflurane in Electroconvulsive Therapy | Biotech Hunter | Biotech Hunter